EGFR-TKIs in adjuvant treatment of lung cancer: to give or not to give?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EGFR-TKIs in adjuvant treatment of lung cancer: to give or not to give?

Published:2015-10 Issue: Volume: Page:2915
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Zarogoulidis Paul,tsirgogianni katerina,Darwiche Kaid,Freitag Lutz,tsavlis drosos,zissimopoulos athanasios,zarogoulidis konstantinos,Stratakos Grigoris,Sarcav Tatiana,Kovacevic Tomi,Zaric Bojan,Stojsic Vladimir,Perin Branislav,Milovancev Alexander

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KIAA0101 promotes cisplatin resistance through regulating cell apoptosis in lung cancer cells;Cellular and Molecular Biology;2023-12-20

2. Profiling of in vivo, in vitro and reactive zorifertinib metabolites using liquid chromatography ion trap mass spectrometry;RSC Advances;2022

3. Cryobiopsy for pneumonitis diagnosis in NSCLC immunotherapy;Respiratory Medicine Case Reports;2022

4. Change in treatment modality and trends in survival among stage I non-small cell lung cancer patients: a population-based study;Journal of Thoracic Disease;2020-09

5. Essential Oils of Lemongrass (Cymbopogon citratus Stapf) Induces Apoptosis and Cell Cycle Arrest in A549 Lung Cancer Cells;BioMed Research International;2020-01-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP